A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate

A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate

**Background/Objectives:** This article compares the effectiveness of baricitinib (BARI) 4 mg (oral, Janus kinase [JAK] 1/2 inhibitor) versus other targeted synthetic/biologic disease-modifying antirheumatic drugs, in combination with methotrexate (MTX), in moderate-to-severe rheumatoid arthritis pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Walid Fakhouri, Xiaofei Wang, Inmaculada de La Torre, Claudia Nicolay
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2020-04-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/jheor.2020.12273
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items